Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Improving the translational hit of experimental treatments in multiple sclerosis.
BIIB033 single ascending dose study in healthy volunteer subjects
American Society for Neurochemistry 46th Annual Meeting
ACTRIMS-ECTRIMS 2014 -- Day 2, afternoon
Episode 59 with Dr. Helmut Butzkueven on the new MS Brain Health initiative
SMC Says Yes to Aubagio® (teriflunomide), a New Once Daily First-line Oral Treatment Available for People with an Active Relapsing Remitting Form of MS
Scientists probe strategies to repair neuron damage in multiple sclerosis.
Episode 62 with Dr. Ellen Mowry on vitamin D and caloric restriction for MS
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
XVI European Charcot Foundation lecture: nutrition and environment, can MS be prevented?
Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
Episode 61 with Dr. Yanming Wang on molecular imaging of the myelin sheathing of axons
Postpartum disease activity and breastfeeding in multiple sclerosis revisited.
Remyelination in experimental models of toxin-induced demyelination.
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.
Positive results from Phase 3 CONFIRM clinical trial show efficacy and safety of oral BG-12 in multiple sclerosis
2015 Annual Meeting of the Consortium of the Multiple Sclerosis Centers
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis.
Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.
Episode 42 with Dr. Lawrence Steinman on amyloid in experimental autoimmune encephalomyelitis
BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec.
Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder.
TECFIDERA® (dimethyl fumarate) approved in the European Union as a first-line oral treatment for multiple sclerosis
FOCiS 2015 Meeting: Immunology by the Bay
Episode 49 with Dr. Hugh Rosen on sphingosine 1-phosphate receptor modulators

Pages